AWM
VCYT icon

Abound Wealth Management’s Veracyte VCYT Stock Holding History

Abound Wealth Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118 Sell
2
-2
-50% -$84 ﹤0.01% 1254
2026
Q1 		$129 Hold
4
– – ﹤0.01% 1359
2025
Q4 		$169 Buy
+4
New +$161 ﹤0.01% 1246

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Abound Wealth Management's VCYT Position: Q2 2026 in Review

Abound Wealth Management reduced its Veracyte (VCYT) stake by 50% in Q2 2026, selling an estimated $84 and leaving 2 shares worth $118. The position accounts for ﹤0.01% of the portfolio, ranked #1254.

Abound Wealth Management first reported a position in VCYT in Q4 2025 and has held it in 3 quarters since. The position peaked at $169 in Q4 2025. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Abound Wealth Management held 2 shares of Veracyte worth $118 as of Q2 2026.
  • Abound Wealth Management sold 2 Veracyte shares in Q2 2026, an estimated $84.
  • Veracyte made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #1254 holding.
  • Abound Wealth Management first reported a position in Veracyte in Q4 2025 and has held it in 3 quarters since.
  • Abound Wealth Management's Veracyte position peaked at $169 in Q4 2025.
  • 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.